Transfer of reducing equivalents between cytosolic compartments and the mitochondrial matrix is mediated by NADH shuttles. Among these, the malate-aspartate shuttle has been proposed to play a major role in β-cells for the control of glucosestimulated insulin secretion. AGC1 or Aralar1 (aspartateglutamate carrier 1) is a key component of the malate-aspartate shuttle. Overexpression of AGC1 increases the capacity of the malate-aspartate shuttle, resulting in enhanced metabolismsecretion coupling, both in INS-1E cells and rat islets. In the present study, knockdown of AGC1 was achieved in the same β-cell models, using adenovirus-mediated delivery of shRNA (small-hairpin RNA). Compared with control INS-1E cells, down-regulation of AGC1 blunted NADH formation (− 57 %; P < 0.05), increased lactate production (+ 16 %; P < 0.001) and inhibited glucose oxidation (− 22 %; P < 0.01). This correlated with a reduced secretory response at 15 mM glucose (− 25 %; P < 0.05), while insulin release was unchanged at intermediate 7.5 mM and basal 2.5 mM glucose. In isolated rat islets, efficient AGC1 knockdown did not alter insulin exocytosis evoked by 16.7 mM glucose. However, 4 mM amino-oxyacetate, commonly used to block transaminases of the malate-aspartate shuttle, inhibited glucose-stimulated insulin secretion to similar extents in INS-1E cells (− 66 %; P < 0.01) and rat islets (− 56 %; P < 0.01). These results show that down-regulation of the key component of the malate-aspartate shuttle AGC1 reduced glucose-induced oxidative metabolism and insulin secretion in INS-1E cells, whereas similar AGC1 knockdown in rat islets did not affect their secretory response.
INTRODUCTION
Biochemical pathways in pancreatic β-cells should optimally translate glucose changes into intracellular signals adjusting the rate of insulin exocytosis. Accordingly, some components of nutrient sensing have been shown to play a major role, in particular those linking two successive pathways. This is the case for reducing equivalent shuttles bridging glycolysis to mitochondrial activation [1] . Different routes have been described for the transfer of reducing equivalents from the cytosol to the mitochondrial matrix; however, the relative contribution and requirement of each of these shuttles remains unclear and debated.
Glucose-stimulated insulin secretion is initiated by the entry of glucose across the plasma membrane and its phosphorylation by glucokinase, thereby promoting glycolysis [2] . Subsequently, pyruvate activates mitochondrial metabolism, generating ATP, which in turn induces the closure of K ATP channels (ATP-sensitive K + channels) and, as a consequence, depolarization of the plasma membrane [3] . This leads to Ca 2+ influx through voltagegated Ca 2+ channels and a rise in cytosolic Ca 2+ concentrations triggering insulin exocytosis [4] . Additional signals are necessary to amplify the action of Ca 2+ and reproduce the sustained secretion evoked by glucose [5] . Efficient coupling of glucose recognition to insulin secretion is ensured by the mitochondrion, an organelle that integrates and generates metabolic signals [6] .
Glycolysis requires continuous reoxidation of cytosolic NADH to NAD + , thereby enabling maintenance of the glycolytic flux. In several tissues, lactate dehydrogenase ensures most of NADH oxidation to avoid inhibition of glycolysis secondary to the lack of NAD + . In β-cells, according to low lactate dehydrogenase activity [7] , a high glycolytic rate is maintained through the activity of mitochondrial NADH shuttles, thereby transferring glycolysis-derived electrons to mitochondria [1] . As a result, NADH shuttles couple glycolysis to activation of mitochondrial energy metabolism, leading to insulin secretion.
The NADH shuttle system is composed essentially of the glycerol-phosphate and the malate-aspartate shuttles, plus the pyruvate shuttles involved in both cytosolic generation of NADPH as well as the process of pyruvate cycling. A key component of the malate-aspartate shuttle is AGC1/Aralar1 (aspartate-glutamate carrier 1) located in the inner mitochondrial membrane [8] and activated by Ca 2+ [9] . AGC1/Aralar1 and AGC2 (aspartateglutamate carrier 2)/citrin are members of the subfamily of Ca 2+ -binding mitochondrial carriers and correspond to two isoforms of the mitochondrial aspartate-glutamate carrier [8, 10] . We have shown that adenoviral-mediated overexpression of AGC1/Aralar1 in insulin-secreting cells increases glucose-induced mitochondrial activation and secretory response [11] . This is accompanied by enhanced glucose oxidation and reduced lactate production [11] . Overexpression of AGC1/Aralar1 also enhances amino-acidstimulated insulin secretion [12] . Therefore aspartate-glutamate carrier capacity appears to set a limit for NADH shuttle function and mitochondrial metabolism. General abrogation of AGC1 in transgenic mice results in severe growth retardation, attributed to the observed impaired central nervous system function [13] .
Regarding the glycerol-phosphate shuttle, mice lacking one of its key components, the mitochondrial glycerol phosphate dehydrogenase, have a normal phenotype [14] . Islets isolated from these mGPDH (mitochondrial glycerol phosphate dehydrogenase)-knockout mice respond normally to glucose regarding metabolic parameters and insulin secretion [14] . However, additional pharmacological inhibition of aminotransferases to block the malate-aspartate shuttle in these knockout islets impairs the secretory response to glucose [14] . Taken together, these findings strongly point to the malate-aspartate shuttle as an essential player in glucose-stimulated insulin secretion.
To date, inhibition of the malate-aspartate shuttle in insulinsecreting cells has been achieved mostly using pharmacological approaches to non-specifically inhibit transaminases with AOA (amino-oxyacetate) [15] [16] [17] [18] . The present study has investigated the consequences of AGC1 knockdown on metabolism-secretion coupling in insulinoma INS-1E cells. Moreover, we crosscompared two approaches to inhibit the malate-aspartate shuttle, i.e. AOA-mediated transaminase inhibition compared with shRNA (small-hairpin RNA)-mediated AGC1 knockdown, both in insulinoma INS-1E cells and primary pancreatic islets.
EXPERIMENTAL

Cell culture
Clonal INS-1E cells [19] , derived and selected from the parental rat insulinoma INS-1 cell line, were cultured in a humidified atmosphere containing 5 % CO 2 in complete medium composed of RPMI 1640 supplemented with 5 % (v/v) heat-inactivated FBS (fetal bovine serum), 1 mM sodium pyruvate, 50 μM 2-mercaptoethanol, 2 mM glutamine, 10 mM Hepes, 100 units/ml penicillin and 100 μg/ml streptomycin. Rat pancreatic islets were isolated by collagenase digestion as described previously [20] , and were cultured free-floating in RPMI 1640 medium before use. Rats used for islet isolation were maintained in our certified animal facility, according to procedures that were approved by the animal care and experimentation authorities of the Canton of Geneva.
Design of siRNA (small interfering RNA) and adenovirus transduction
Various siRNA constructs were designed from the rat AGC1 cDNA sequence as a hairpin-loop structure using the Ambion website tool (http://www.ambion.com/techlib/misc/ siRNA_finder.html). These constructs were tested by cloning into a pSilencer plasmid and their respective potency was assessed by performing Lipofectamine TM (Invitrogen)-mediated transfection in INS-1E cells and immunoblotting against AGC1 (see below). The most efficient siRNA cassette was used to generate a recombinant adenovirus as described previously [21] , and is referred to as AdshAGC1.
Adherent cultured INS-1E cells were transduced with recombinant AdshAGC1 virus at a titre of 30 PFU (plaque-forming units)/ml for 60 min, and experiments were performed 4 days after transduction. An Empty adenoviral construct used at the same titre served as a control for viral infection. Regarding rat islets, the transduction was performed on the day of isolation at a titre of 60 PFU/ml for 90 min. As for INS-1E cells, experiments were performed at 4 days post-transduction. Transduced islets were kept in culture for 4 days before insulin secretion assays.
Immunoblotting
Total cell extracts were produced by lysing cells in a buffer containing 20 mM Tris/HCl (pH 7.4), 0.1 M EDTA, 0.1 M EGTA, 5 % (v/v) 2-mercaptoethanol and 20 % Triton X-100 supplemented with 1 mM PMSF. Protein extracts (30 μg) were subjected to SDS/PAGE [11 % (w/v) polyacrylamide gel] before transfer on to a nitrocellulose membrane, which was incubated overnight at 4
• C in the presence of an anti-AGC1 antibody (1:2000 dilution) [11] and an anti-actin antibody (1:1000 dilution; Chemicon). Then, the membrane was probed for 1 h at room temperature (22 • C) with a donkey anti-(rabbit IgG) antibody conjugated to HRP (horseradish peroxidase) (1:5000; Amersham Biosciences) or an anti-(mouse IgG) antibody conjugated to HRP (1:5000; GE Healthcare). Both AGC1 and actin were revealed by chemiluminescence (Pierce).
Fluorescence measurements
Metabolic parameters were measured using fluorescent probes. INS-1E cells grown in 24-well plates were transduced with Empty or AdshAGC1 adenovirus 4 days before the experiments. Cells were then pre-incubated in glucose-free culture medium, washed and pre-incubated further in glucose-free KRBH (Krebs-Ringer bicarbonate Hepes) buffer [135 mM NaCl, 3.6 mM KCl, 10 mM Hepes (pH 7.4), 5 mM NaHCO 3 , 0.5 mM NaH 2 PO 4 , 0.5 mM MgCl 2 and 1.5 mM CaCl 2 ] for 30 min. The 24-well plates were then transferred to a thermostated (37
• C) fluo-lumino plate reader (Fluostar Optima; BMG Labtechnologies). Test compounds were added as indicated using automated built-in microinjectors.
NADPH autofluorescence was measured using excitation and emission filters set at 340 and 470 nm respectively. NADPH autofluorescence was normalized over a 10-min stimulation period by setting the fluorescence at 100 % for cells maintained in basal 2.5 mM glucose [11] .
ψ m (mitochondrial membrane potential) was measured using the fluorescent probe rhodamine-123, with excitation and emission filters set at 485 and 530 nm respectively [22] . Transduced cells were loaded with 10 μg/ml rhodamine-123 (Molecular Probes) for 20 min at 37
• C in KRBH buffer. After washes, the successive effects of 15 mM glucose (additions on top of basal 2.5 mM glucose) and 1 μM of the protonophore FCCP (carbonyl cyanide p-trifluoromethoxyphenylhydrazone) were tested.
Cytosolic Ca 2+ changes were monitored in cells pre-incubated for 90 min with 2 μM fura 2/AM (fura 2 acetoxymethyl ester; Teflab) in KRBH buffer at 37
• C and then washed before the experiments. Ratiometric measurements of fura 2 fluorescence were performed with filters set at 340/380 nm for excitation and 510 nm for emission [23] .
Cellular ATP, lactate and glutamate concentrations
Cellular ATP concentrations were determined in cells transduced with Empty or AdshAGC1 adenovirus, following 10 min glucose of stimulation, using the ATP Bioluminiscent assay kit (Roche).
Glutamate concentrations were determined following 30 min of incubation with 2.5 and 15 mM glucose, as described previously [24] , normalized to cellular protein content.
Lactate released into the medium was determined following the 4-day post-transduction period. Then, after a 24-h culture period, medium was collected for measurement of lactate concentration determined as NADH generated from NAD + in the presence of an excess lactate dehydrogenase, as described previously [11] . 
Glucose utilization and oxidation
Insulin secretion assay
The secretory responses to increasing concentrations of glucose were tested in INS-1E cells transduced with Empty and AdshAGC1 viruses. Briefly, after washes with glucose-free KRBH buffer containing 0.1 % BSA as an insulin carrier, cells were stimulated with the indicated glucose concentrations for 30 min. Non-nutrient-stimulated insulin release was induced by the Ca 2+ -raising agent KCl (30 mM) at basal 2.5 mM glucose. Where indicated, the transaminase inhibitor AOA was added to block activity of the malate-aspartate shuttle. Incubations were stopped by putting the plates on ice, supernatants were collected for insulin secretion, and cellular insulin contents were determined from acid-ethanol extracts. Insulin secretion was measured by RIA using rat insulin as a standard and results are expressed as a percentage of content.
At 4 days after transduction, isolated rat islets were washed, hand-picked and distributed into 3 ml tubes in KRBH buffer for static incubation over a 30 min period, as detailed previously [26] . Islet perifusions were carried out using ten hand-picked islets per chamber of 250 μl volume, thermostated at 37
• C (Brandel). The flux was set at 0.5 ml/min and fractions were collected every min after a 20 min washing period at basal 2.8 mM glucose. Then, fractions were collected for 15 min with circulating KRBH buffer at 2.8 mM glucose before 20 min at 16.7 mM. Insulin levels were determined by RIA using rat insulin as a standard and were normalized per number of islets/chamber.
Real-time quantitative RT-PCR (reverse transcription-PCR)
Total RNA was extracted from transduced INS-1E cells using TRIzol ® , as described previously [23] . cDNA was synthesized from total RNA using SuperScript TM reverse transcriptase and random primers (Invitrogen). The real-time PCR measurement of cDNAs was performed using Power SYBR Green PCR Master Mix (Applied Biosystems) to measure duplex DNA formation and was normalized to the expression of both TFIIb (transcription factor IIb) and α-tubulin as control housekeeping genes. The real-time RT-PCR used the following primers (sense and antisense respectively): AGC1/Aralar1, 5 -AGGTGGACGGAGAGCATTACA-3 and 5 -GGGTTGCT-GTTCGGATCATT-3 ; AGC2/citrin, 5 -GCGATGGTTCTACG-TCGATT-3 and 5 -ACAGCGGTCACTTTTGAGGT-3 ; MDH (malate dehydrogenase), 5 -TCAGTTGCCTGACTCGATTG-3 and 5 -TTTCACCTTGGCATGATTGA-3 , Me1 (cytosolic malic enzyme), 5 -GCCCTGAATATGATGCGTTT-3 and 5 -CACA-GACGCTGTTCCTTGAA-3 ; mGPDH, 5 -GAGTTGCGACGT-TGAAGTGA-3 and 5 -GGGTCCTGCATTCAAGTTGT-3 ; and PC (pyruvate caboxylase), 5 -GGCGAATTCCGATGGCAATC-TCACCTCTGTTGGC-3 and 5 -GGCTTGAGGCGACGGG-GCGAAG-3 .
Statistics
Unless otherwise indicated, results are expressed as the means + − S.E.M. from at least three independent experiments. Differences between groups were assessed using a Student's t test for single comparisons and by ANOVA, followed by Bonferroni t test, for multiple comparisons. A P value <0.05 was considered as significant.
RESULTS
Assessment of AGC1 knockdown in INS-1E cells
Reduction in AGC1 expression was assessed by immunoblotting 4 days after transduction with AdshAGC1 virus ( Figure 1A ). As controls, cells transduced with Empty virus had basal expression of AGC1 in INS-1E cells, and overexpression was induced by an adenovirus used in a previous study [11] . AdshAGC1 mediated an efficient decrease in AGC1 expression as, on average, densitometry analysis indicated a 40 % reduction in AGC1 protein. Down-regulation was confirmed by quantitative RT-PCR (Table 1) , showing specificity for AGC1 without changes in AGC2 expression.
The malate-aspartate shuttle mediates the robust elevation of NADH upon glucose stimulation [11] . Accordingly, a decrease in its activity should be translated into blunted NADH increases. Exposure of control INS-1E cells to stimulatory 15 mM glucose induced a sustained elevation of NADH levels ( Figure 1B) . In cells transduced with AdshAGC1, glucose-evoked increases in NADH levels were inhibited (− 57 %; P < 0.05) compared with control cells. This first set of results showed efficient functional impairment of the malate-aspartate shuttle through knockdown of its key component AGC1. To determine whether overall mitochondrial activation would be affected by AGC1 down-regulation, we measured ψ m . In control cells transduced with the Empty virus, the mitochondrial membrane was hyperpolarized by raising glucose from basal 2.5 mM to 15 mM (Figure 2A ). Further addition of the protonophore FCCP (1 μM) resulted in a rapid depolarization, reflecting dissipation of the proton gradient. A similar profile was observed in cells transduced with AdshAGC1, indicating that down-regulation of AGC1 did not alter electron transport chain activity. Cellular ATP concentrations were measured in INS-1E-transduced cells. In control cells, stimulation with 15 mM glucose increased cellular ATP content by 22.6 % (P < 0.01) compared with basal conditions at 2.5 mM glucose ( Figure 2B ). Knockdown of AGC1 limited the glucose-induced ATP increase to 12.2 % (P < 0.05), showing a slight reduction in ATP levels at 15 mM glucose compared with control cells (− 9.9 %; P < 0.01).
Increases in cytosolic Ca 2+ are necessary to trigger insulin exocytosis, although it is not sufficient for the full development of the glucose response. We checked whether AGC1 downregulation would affect glucose-evoked cytosolic Ca 2+ increases. As shown in Figure 2 
Effects of AGC1 down-regulation on glucose metabolism, lactate production and glutamate levels
Glucose utilization reflects glycolytic flux, and glucose complete oxidation to 14 CO 2 shows the mitochondrial fate of glucose metabolism. We measured glucose utilization as the rate of 3 H 2 O formation from 15 mM D- [5- 3 H]glucose. This parameter was not modified in cells transduced with the AdshAGC1 construct when compared with Empty-transduced cells ( Figure 3A) . Glucose oxidation to 14 
CO 2 was measured in transduced INS-1E cells over a 1 h stimulation period with 15 mM [U-
14 C]glucose ( Figure 3B ). Compared with control cells, knockdown of AGC1 decreased glucose oxidation by 22 % (P < 0.01). Therefore the observed reduced mitochondrial oxidative activity was not the consequence of a lower glycolytic rate.
At the end of the glycolytic cascade, pyruvate can either be reduced to lactate or transferred to mitochondria for further oxidation to CO 2 . Lactate production by INS-1E cells with the down-regulation of AGC1 was increased 16 % (P < 0.01) compared with controls ( Figure 3C ). Since the glycolytic rate was unchanged ( Figure 3A) , it is interesting to note that the lack of oxidation to CO 2 ( Figure 3B ) was counter-balanced by increased lactate production (Fig. 3C ).
An alternative fate of glucose metabolism is the formation of glutamate [24] , favoured by high NADH levels [27] . As shown in Figure 3(D) , measurements of cellular glutamate concentrations at 15 mM glucose showed that AGC1 knockdown decreased cellular glutamate concentrations by 21 % (P < 0.05).
Gene expression analysis in transduced INS-1E cells
Gene expression analysis was performed to test whether suppression of a key component of the malate-aspartate shuttle would modify expression of genes encoding for enzymes implicated in alternative pathways for the transport of reducing equivalents to mitochondria.
First, we investigated the effect of AGC1 suppression with respect to its isoform AGC2, also commonly referred to as citrin. AGC2/citrin has been found to be predominantly expressed in the liver and small intestine [28] , and at very low levels in INS-1E cells and rat islets [11] . As shown in Table 1 , down-regulation of AGC1 did not induce compensatory AGC2 expression at either day 2 or day 4 post-transduction.
Next, we examined the glycerol-phosphate and the pyruvatecitrate shuttles through the expression of their key members mGPDH and Me1 respectively. Knockdown of AGC1 did not modify the expression of mGPDH, although the expression of Me1 was slightly reduced at day 4 (Table 1) .
MDH, which promotes the conversion of oxaloacetate into malate, was tested as this enzyme is implicated in both the malate-aspartate and pyruvate-citrate shuttles. Its expression was reduced 30 % (P < 0.05) in AdshAGC1-treated cells 4 days posttransduction compared with controls. This could be explained as a response to parallel knockdown of an essential component (i.e. AGC1) of the malate-aspartate shuttle. Finally, cycling capacity of pyruvate was estimated by measuring PC expression, a mitochondrial enzyme responsible for the conversion of pyruvate into oxaloacetate. PC expression was not modified by AGC1 down-regulation, preserving pyruvate cycling capacity.
Effects of AGC1 down-regulation and the transaminase inhibitor AOA on insulin secretion in INS-1E cells
As shown in Figure 4 , INS-1E cells were assayed for secretory responses 4 days after adenoviral transduction. Cells were incubated for a 30-min stimulatory period at basal 2.5 mM, intermediate 7.5 mM and high 15 mM glucose. The secretory responses in control cells exhibited a glucose dose-response with a 3.0-fold (P < 0.001) increase upon 15 mM glucose compared with basal release ( Figure 4A ). In cells treated with AdshAGC1, we observed similar insulin release at basal and intermediate glucose concentrations, although the response to high glucose was reduced by 25 % compared with control INS-1E cells (P < 0.05). The secretory response to nutrient-independent stimulation was tested by K + -induced depolarization and showed preserved Ca 2+ -evoked secretion. These results demonstrate that reduced AGC1 expression blunted insulin secretion evoked by a high glucose concentration. The transaminase inhibitor AOA was tested as it has been used in several studies to investigate the role of the malate-aspartate shuttle in insulin secretion. As shown in Figure 4 (B), insulin secretion stimulated by 15 mM glucose was reduced 66 % in the presence of 4 mM AOA compared with the secretory response in control cells (P < 0.01). Therefore AOA-mediated inhibition of the malate-aspartate shuttle exhibited a stronger reduction in the secretory response compared with knockdown of its key component AGC1. Effects of the transaminase inhibitor AOA and AGC1 down-regulation on insulin secretion in isolated rat islets AOA was also tested on glucose-stimulated insulin secretion in isolated rat islets ( Figure 5A ). Control islets exhibited a 6.2-fold secretory response at 16.7 mM glucose over basal release (P < 0.001). Addition of 4 mM AOA resulted in a large reduction in the 16.7 mM glucose response (− 56 %; P < 0.01), similar to the inhibition observed in INS-1E cells.
Islets transduced with Empty and AdshAGC1 viruses were analysed 4 days later by immunoblotting to check the efficiency of the siRNA construct in primary cells. Similarly to INS-1E cells, we observed a clear reduction (approx. 40 %) in AGC1 protein levels when compared with control islets ( Figure 5B) . Next, insulin secretory responses were determined in pancreatic islets that were transduced with Empty and AdshAGC1 viruses, both in static incubations ( Figure 5C ) and in perifusion experiments ( Figure 5D ). In static incubations, islets exhibited robust glucosestimulated insulin secretion in both groups ( Figure 5C ). In perifusion experiments, control islets exhibited a sustained elevation of the secretory response at 16.7 mM glucose, with a plateau phase 7.0-fold higher than basal release ( Figure 5D ). AdshAGC1-transduced islets responded to stimulatory 16.7 mM glucose with similar amplitudes as control islets. These results are in contrast with those obtained using AOA in islets ( Figure 5A ) and also with the responses observed in AdshAGC1-transduced INS-1E cells ( Figure 4A ).
DISCUSSION
In a previous study, we have shown that overexpression of AGC1 increases the capacity of the malate-aspartate shuttle, resulting in enhanced oxidative metabolism and potentiation of glucosestimulated insulin secretion, effects observed both in INS-1E cells and rat islets [11] . It could be expected that down-regulation of AGC1 would exhibit mirror effects in the corresponding cell models. The present study shows that such an assumption is only partially correct. In glucose-stimulated insulinoma INS-1E cells, knockdown of AGC1 blunted NADH formation and inhibited glucose oxidation. This correlated with a reduced generation of mitochondrial metabolic products, i.e. ATP and glutamate. Of note, in AGC1-knockdown cells, the glucose-evoked ATP increase was blunted, while mitochondrial hyperpolarization was unchanged. This apparent paradox might be explained by lower mitochondrial pyruvate import, indicated by the switch from glucose oxidation to lactate production, thereby attenuating the accompanying mitochondrial depolarization [29] . In AGC1-knockdown INS-1E cells, insulin secretion was lowered at a high (15 mM) glucose concentration, whereas it was unchanged at an intermediate (7.5 mM) glucose concentration. These results are in accordance with the overexpression study, showing that suppression of AGC1 mirrored the overexpression study in INS-1E cells [11] . However, efficient knockdown of AGC1 in primary cells in the form of isolated islets did not alter the secretory response.
It is interesting to note that AGC1 knockdown in INS-1E cells reduced glucose oxidation, while glycolytic flux was preserved (Figure 3 ). This lack of correlation between two successive pathways was observed previously in mouse islets deficient in NADH shuttle systems [14] . Conversely, enhanced capacity of the malate-aspartate shuttle, achieved by overexpression of AGC1, increases glucose oxidation and lowers lactate production without affecting the glycolytic rate [11] . Pyruvate, formed through glycolysis, can be reduced to lactate, thereby regenerating cytosolic NAD + . Alternatively, the malate-aspartate shuttle can transfer reducing equivalents carried by cytosolic NADH to mitochondrial NAD + . In the present study, down-regulation of AGC1 reduced glucose oxidation and increased lactate production with a preserved glycolytic rate. Taken together, these studies show that modulation of NADH shuttle capacity does not affect the glycolytic rate, although it determines the fate of the glycolytic product pyruvate. High NADH shuttle activity drives pyruvate into mitochondria, although reduced activity of the shuttle favours lactate release at the expense of mitochondrial oxidation. In this context, NADH shuttles act as metabolic switches controlling the fate of pyruvate through the transfer of reducing equivalents.
The importance of the malate-aspartate shuttle in β-cells was first suggested in studies making use of AOA to pharmacologically inhibit transaminases [15, 17] . In the present study, we could crosscompare the effects of AOA and AGC1 knockdown in INS-1E cells and isolated islets. While 4 mM AOA inhibited glucosestimulated insulin secretion in both cell models, AGC1 downregulation did not affect the secretory response in islets (Figures 4  and 5) . Additionally, insulin secretion in INS-1E cells was affected much more by 4 mM AOA than by down-regulation of AGC1. This strongly suggests that the effects of AOA should be analysed with great caution, as general inhibition of transaminases probably affects other important pathways not restricted to the malateaspartate shuttle.
AOA was originally used in the early 1970s by researchers investigating gluconeogenesis in liver [30] and kidney cortex [31] . In these studies, AOA was used at a concentrations below the millimolar range, principally at 0.1 mM [30, 31] . Later, AOA was then used in rodent islets, again to inhibit transaminase-dependent NADH shuttles, although at much higher concentrations, i.e. typically at 5 mM [14, 15, 17, 18] . Of note, the effects of AOA were found to be more pronounced in rat [15, 17] compared with mouse [14, 18] islets. According to the results of the present study showing a lack of correlation between the use of 4 mM AOA and knockdown of AGC1, findings obtained previously when using 5 mM AOA might be revisited for a potential alternative interpretation.
It is striking that down-regulation of AGC1 inhibited glucosestimulated insulin secretion in insulinoma INS-1E cells but not in primary islet β-cells (Figures 4 and 5) . Regarding the opposite manoeuvre, we have observed previously that overexpression of AGC1 potentiates the glucose response both in INS-1E cells and rat islets [11] . Comparing the results of the present studies with those published previously show a lack of mirror effects regarding the malate-aspartate shuttle. Therefore insulinsecreting cells exhibit strong dependence on the malate-aspartate shuttle, although islet cells do not. Such a discrepancy between insulinoma and primary β-cells has been reported recently concerning another mitochondrial shuttle, namely the pyruvatecitrate shuttle. Abrogation of a key component of the pyruvatecitrate shuttle, i.e. the malic enzyme, was shown to inhibit glucosestimulated insulin secretion in insulinoma cells [32, 33] ; however, such effects have not been reproduced in primary cells in the form of rodent islets [34] . Taken together, these results on the malate-aspartate and pyruvate-citrate shuttles shed new light on the possible adaptation of tumour-derived insulin-secreting cells. It could be hypothesized that proliferating cells would be more dependent on mitochondrial shuttles than primary nondividing cells. This could be of interest for our comprehension on tumour differentiation and growth, in particular regarding pathways serving as redox state sensors.
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